头颈部放疗在随机对照试验中的报告质量
该临床综述检索 MEDLINE 1994 至 2015 年符合条件的随机对照试验,评估头颈癌放疗报告质量及其对疗效与毒性结果报告偏倚的影响。协作组试验更可能达到合格质量(OR 3.02,95%CI 1.04-9.85)。放疗报告质量未影响试验结果报告的偏倚。
要点
- 协作组试验的放疗报告质量更可能合格(OR 3.02,95%CI 1.04-9.85)。
- 放疗报告质量未影响试验疗效与毒性结果报告的偏倚。
核心结论
- 头颈癌随机对照试验中放疗报告质量参差不齐,且未影响试验结果报告的偏倚。
研究设计与样本
- 临床综述,检索 MEDLINE 1994 至 2015 年发表的符合条件的头颈癌随机对照试验,共纳入 67 篇试验报告,采用已发表标准评估放疗报告质量与结果报告偏倚。
主要发现
- 纳入试验的放疗治疗报告质量存在显著差异。
- 协作组试验更可能具有合格质量的报告(OR 3.02;95%CI 1.04-9.85)。
- 放疗报告质量未影响试验结果报告中的偏倚。
关键数值与推荐
- 协作组试验与合格质量报告的关联:OR 3.02;95%CI 1.04-9.85。
临床怎么用
- 解读头颈癌随机对照试验时需注意其放疗报告质量可能存在差异。
- 协作组试验的放疗报告质量可能相对更可靠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this clinical review was to determine the quality reporting of radiotherapy (RT) in randomized controlled trials (RCTs) of head and neck cancer and its impact on reporting of the trial primary efficacy and toxicity outcomes. METHODS: We searched MEDLINE for eligible RCTs published between 1994 and 2015. We assessed the quality of RT reporting and bias in the reporting of trial outcomes using published criteria. RESULTS: We found 67 eligible trial reports. There was significant variability in the quality of RT treatment reporting among the included trials. Thirty-two trials had adequate quality RT reporting. Cooperative group trials were more likely to have adequate quality reporting (odds ratio [OR] 3.02; 95% confidence interval [CI] 1.04-9.85). The quality of RT reporting did not influence the bias in the reporting of trial outcomes. CONCLUSION: The quality of head and neck RT reporting in RCTs is variable and did not impact on bias in reporting of trial outcomes.
引用
- Tseng M, Tan TH, Zheng H, et al. Quality of head and neck radiotherapy reporting in randomized controlled trials. Head Neck. 2018. PMID: 29575476. doi:10.1002/hed.25133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。